Skip to main content

CORRECTION article

Front. Med., 11 July 2023
Sec. Translational Medicine

Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome

\r\nQiufeng Xiao,,,&#x;Qiufeng Xiao1,2,3,4Xunyao Wu&#x;Xunyao Wu5Chuiwen Deng,,,Chuiwen Deng1,2,3,4Lidan Zhao,,,Lidan Zhao1,2,3,4Linyi Peng,,,Linyi Peng1,2,3,4Jiaxin Zhou,,,
Jiaxin Zhou1,2,3,4*Wen Zhang,,,Wen Zhang1,2,3,4Yan Zhao,,,Yan Zhao1,2,3,4Yunyun Fei,,,
Yunyun Fei1,2,3,4*
  • 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 2National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science and Technology, Beijing, China
  • 3State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 4Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China
  • 5Clinical Biobank, Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

A corrigendum on
The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome

by Xiao, Q., Wu, X., Deng, C., Zhao, L., Peng, L., Zhou, J., Zhang, W., Zhao, Y., and Fei, Y. (2022). Front. Med. 9:959388. doi: 10.3389/fmed.2022.959388

In the published article, there was an error in affiliation 1. Instead of “Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China”, it should be “Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: primary Sjögren's syndrome, N6-methyladenosine, METTL3, ALKBH5, YTHDF readers, ISG15

Citation: Xiao Q, Wu X, Deng C, Zhao L, Peng L, Zhou J, Zhang W, Zhao Y and Fei Y (2023) Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome. Front. Med. 10:1251795. doi: 10.3389/fmed.2023.1251795

Received: 02 July 2023; Accepted: 03 July 2023;
Published: 11 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Xiao, Wu, Deng, Zhao, Peng, Zhou, Zhang, Zhao and Fei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jiaxin Zhou, pumczhou@sina.com; Yunyun Fei, feiyunyun@pumch.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.